Literature DB >> 28251091

A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population.

Man-Hin Lui1, Jason Chun Ho Lam1, Yi Lee Kwong1, Tak Siu Wong1, Pak Long Cheung1, Sherri Shun Yan Lai1, Pak Lun Yuen1, Wai Yiu Lam1, Ho Yan Chan1, Yiu Fai Wong1, Jimmy Shiu Ming Lai2, Kendrick Co Shih2.   

Abstract

AIM: To estimate the overall drug compliance for local Chinese glaucoma patients on long-term topical treatment.
METHODS: This was a retrospective cross-sectional study. Fifty-seven primary glaucoma patients from the subspecialty clinic of a publicly-funded tertiary care hospital in Hong Kong completed a questionnaire on compliance with topical glaucoma medication, attitude towards glaucoma and therapy and vision related quality of life. Noncompliance was defined as reporting missing more than or equal to 10% of the prescribed topical glaucoma medication during the 2wk immediately prior to the consultation. Relationships between noncompliance and demographics, attitude, disease and treatment status was studied. Cost was estimated with quality of life and direct medical cost involved with noncompliance. Multivariable logistic regression on noncompliance was performed on selected factors.
RESULTS: Compliance was calculated as 75% (95% CI: 64%-87%) among 57 subjects (mean age 69y, female 51%). No statistical significant relationship was established between noncompliance and any single factors or outcomes. Age (P=0.048) and forgetfulness (P=0.064) were found to be marginally significant predictive factors on noncompliance in multivariable logistic regression. Noncompliance might be related (P=0.130) to poorer self-rated vision-associated quality of life. The societal cost of noncompliance was estimated to be over 2510 life-years and US$ 3.7 million territory-wide.
CONCLUSION: The compliance of Chinese glaucoma patients in Hong Kong is comparable to other parts in the world, and carries detrimental impacts on individual and societal levels. Age and forgetfulness are two possible independent predictors for noncompliance.

Entities:  

Keywords:  compliance; eye drop; glaucoma; quality of life

Year:  2017        PMID: 28251091      PMCID: PMC5313555          DOI: 10.18240/ijo.2017.02.18

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  17 in total

1.  Compliance and knowledge about glaucoma in patients at tertiary glaucoma units.

Authors:  Kaweh Mansouri; Milko E Iliev; Kaspar Rohrer; Tarek Shaarawy
Journal:  Int Ophthalmol       Date:  2011-10-07       Impact factor: 2.031

2.  Noncompliance with medical treatment among glaucoma patients in Oman--a cross-sectional descriptive study.

Authors:  Rajiv Khandekar; Mona El-Sayed Shama; Ali Jaffer Mohammed
Journal:  Ophthalmic Epidemiol       Date:  2005-10       Impact factor: 1.648

3.  Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe.

Authors:  C E Traverso; J G Walt; S P Kelly; A H Hommer; A M Bron; P Denis; J-P Nordmann; J-P Renard; A Bayer; F Grehn; N Pfeiffer; C Cedrone; S Gandolfi; N Orzalesi; C Nucci; L Rossetti; A Azuara-Blanco; A Bagnis; R Hitchings; J F Salmon; G Bricola; P M Buchholz; S V Kotak; L M Katz; L R Siegartel; J J Doyle
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

Review 4.  Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.

Authors:  Christine M G Olthoff; Jan S A G Schouten; Bart W van de Borne; Carroll A B Webers
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

5.  A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.

Authors:  Paul P Lee; John G Walt; John J Doyle; Sameer V Kotak; Stacy J Evans; Donald L Budenz; Philip P Chen; Anne L Coleman; Robert M Feldman; Henry D Jampel; L Jay Katz; Richard P Mills; Jonathan S Myers; Robert J Noecker; Jody R Piltz-Seymour; Robert R Ritch; Paul N Schacknow; Janet B Serle; Gary L Trick
Journal:  Arch Ophthalmol       Date:  2006-01

6.  The economic burden of major adult visual disorders in the United States.

Authors:  David B Rein; Ping Zhang; Kathleen E Wirth; Paul P Lee; Thomas J Hoerger; Nancy McCall; Ronald Klein; James M Tielsch; Sandeep Vijan; Jinan Saaddine
Journal:  Arch Ophthalmol       Date:  2006-12

7.  Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment.

Authors:  Antoine Regnault; Muriel Viala-Danten; Hélène Gilet; Gilles Berdeaux
Journal:  BMC Ophthalmol       Date:  2010-02-01       Impact factor: 2.209

Review 8.  Interventions for improving adherence to ocular hypotensive therapy.

Authors:  Heather Waterman; Jennifer R Evans; Trish A Gray; David Henson; Robert Harper
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

Review 9.  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.

Authors:  Yih-Chung Tham; Xiang Li; Tien Y Wong; Harry A Quigley; Tin Aung; Ching-Yu Cheng
Journal:  Ophthalmology       Date:  2014-06-26       Impact factor: 12.079

10.  Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative study.

Authors:  Jean-Philippe Nordmann; Philippe Denis; Marc Vigneux; Elyse Trudeau; Isabelle Guillemin; Gilles Berdeaux
Journal:  BMC Health Serv Res       Date:  2007-08-06       Impact factor: 2.655

View more
  1 in total

1.  Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China.

Authors:  Chenjia Xu; Ruru Guo; Dandan Huang; Jian Ji; Wei Liu
Journal:  J Ophthalmol       Date:  2020-07-30       Impact factor: 1.909

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.